BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

16 related articles for article (PubMed ID: 11045168)

  • 1. [Importance of determining the propidium-iodide index of plasmacytes in multiple myeloma. I. Relation to selected laboratory indicators of the disease].
    Scudla V; Ordeltová M; Spidlová A; Bacovský J; Kurasová J; Vránová M
    Vnitr Lek; 1999 Jun; 45(6):331-5. PubMed ID: 11045167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A contribution to examination of propidium iodide and annexin V plasma cells indices in multiple myeloma.
    Scudla V; Ordeltova M; Bacovsky J; Vytrasova M; Sumna E; Martinek A; Horak P
    Neoplasma; 2003; 50(5):363-71. PubMed ID: 14628090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relation of the soluble cytoadhesion molecules VCAM-1 and ICAM-1 to selected clinical and laboratory indicators in multiple myeloma].
    Scudla V; Budíková M; Bacovský J; Ordeltová M; Opíchalová D; Heincová V
    Vnitr Lek; 1999 Oct; 45(10):583-90. PubMed ID: 10951865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of plasma cell propidium iodide and annexin-V indices and their mutual ratio in multiple myeloma.
    Scudla V; Ordeltova M; Minarik J; Dusek L; Zemanova M; Bacovsky J
    Neoplasma; 2006; 53(3):213-8. PubMed ID: 16652190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of plasmatic cell proliferation and apoptosis indexes in the course of multiple myeloma].
    Minarík J; Scudla V; Ordeltová M; Bacovský J; Zemanová M; Pika T
    Vnitr Lek; 2008 Jan; 54(1):31-5. PubMed ID: 18390115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Importance of determining the propidium-iodide index of plasmacytes in multiple myeloma. II. Relation to disease extent and activity].
    Scudla V; Ordeltová M; Spidlová A; Bacovský J; Budíková M; Srovnalík K
    Vnitr Lek; 1999 Jun; 45(6):336-41. PubMed ID: 11045168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotypic aberrations, DNA content, and cell cycle analysis of plasma cells in patients with myeloma and monoclonal gammopathies.
    Lima M; Teixeira Mdos A; Fonseca S; Gonçalves C; Guerra M; Queirós ML; Santos AH; Coutinho A; Pinho L; Marques L; Cunha M; Ribeiro P; Xavier L; Vieira H; Pinto P; Justiça B
    Blood Cells Mol Dis; 2000 Dec; 26(6):634-45. PubMed ID: 11358356
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.